While both medications belong to a class of drugs known as GLP-1 receptor agonists, they are not identical
Clinical Evidence A study published in the New England Journal of Medicine followed 47 MCAS patients : 89% showed improvement in symptoms, including allergic, neurologic, digestive, and inflammation-related reactions Improvements happened within hours to days Only 13% experienced weight loss , and none became underweight Consistency is crucial
The SURMOUNT trials measured outcomes at 72 weeks, showing substantial weight loss that continued throughout the treatment period
When food reaches these cells, they release GLP-1 into your bloodstream, where it signals your pancreas to produce insulin, tells your brain youre full, and slows gastric emptying so you feel satisfied longer
This potential association has led to interest in L-citrulline as a potential option for supporting nitric oxide levels in the body